Intelligence is the ability to adapt to change.
One of the most exciting aspects of medicine as a career is that as our knowledge evolves so should our clinical practice. As anesthesiologists, we should expect how we deliver perioperative care to patients to be different in the future as new discoveries are made. Anesthesiologists not only need to adapt to changes over the span of their careers, we must also be able to respond appropriately to immediate changes in the patient in the perioperative environment. All 3 articles in the Congenital Cardiac Forum illustrate this. The first article by Cvetkovic et al presents a case of severe coronary artery disease in a 14-year-old patient with a rare variant in the PA-1 (SERPINE) gene. 1 The authors discuss causes of coronary artery disease including rare causes such as this prothrombotic genetic variant and its clinical implications. The second article by Latham et al presents a case of heparin-induced thrombocytopenia in a child on extracorporeal life support who then underwent heart transplantation after transitioning to argatroban for anticoagulation management. 2 The authors provide an excellent overview of heparin-induced thrombocytopenia and alternative anticoagulation management strategies for extracorporeal life support and cardiopulmonary bypass. The final article by Schwartz et al is potentially an early warning about a drug that is being used commonly in congenital cardiac anesthesiology. 3 The authors present a case of cardiac arrest in a patient who is receiving dexmedetomidine during cardiac catheterization for heart transplant surveillance and conclude that dexmedetomidine should be used with caution in pediatric heart transplant patients.
In all these reports, the anesthesiologists have quickly adapted to changes in their patients and worked as part of a team. These immediate responses and teamwork are part of our everyday clinical practice as we respond to changing physiology, modifications of the surgical plan, and unexpected events. The future perioperative care of patients with congenital heart disease will be shaped by how we adapt to changes in our specialty and how we engage with others in the health care team to influence positive changes for our patients.
